15. Conclusion
Cancer patients are at an exceptionally high risk of developing
SARS-CoV-2 infection and are also likely to have higher morbidity and
mortality, prompting the need for special attention to be paid to this
population. In general, three strategies can be undertaken to manage
cancer patients during the COVID-19 pandemic: 1) delaying chemotherapy
or elective surgeries in stable patients; 2) implementing strict
personal precautions for every cancer patient; and 3) providing more
intensive care and treatment to cancer patients infected with
SARS-CoV-2. In brief, it is recommended that curative cancer treatment
should be continued, despite the potential higher risk of being infected
with SARS-CoV-2 during anticancer therapy. Nevertheless, surgeries may
be postponed based on the clinicians’ judgment, and this at-risk
population should be prioritized in the vaccination program.